F-STAR THERAPEUTICS INC (FSTX)
US30315R1077 - Common Stock
| MRQ (2022-9-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 35.57M | 78.55M | 18.53M | 28.71M | 14.72M | |||
| Marketable Securities | N/A | N/A | N/A | 25.75M | 32.91M | |||
| Receivables | 8.14M | 2.31M | 3.56M | N/A | N/A | |||
| Other Current Assets | 5.90M | 3.88M | 3.98M | 3.52M | 1.65M | |||
| Total Current Assets | 49.61M | 84.74M | 26.07M | 57.98M | 49.29M | |||
| Non-Current Assets | ||||||||
| PPE Net | 3.38M | 4.17M | 3.57M | 4.95M | 2.32M | |||
| Investments And Advances | N/A | N/A | N/A | 0.00 | 16.80M | |||
| Goodwill | 14.12M | 14.90M | 14.93M | N/A | N/A | |||
| Intangibles | 16.20M | 18.77M | 18.99M | N/A | N/A | |||
| Other Non-Current Assets | 412.00K | 451.00K | 60.00K | 270.00K | 400.00K | |||
| Total Non-Current Assets | 34.11M | 38.28M | 37.54M | 5.22M | 19.52M | |||
| TOTAL ASSETS | 83.72M | 123.02M | 63.61M | 63.20M | 68.81M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 1.31M | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 8.57M | 7.15M | 10.00M | 3.20M | 2.37M | |||
| Accounts Payable | 2.50M | 3.08M | 4.60M | 2.21M | 1.88M | |||
| Other Current Liabilities | 2.29M | 1.91M | 2.38M | N/A | N/A | |||
| Total Current Liabilities | 14.68M | 12.13M | 16.98M | 5.41M | 4.25M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 8.53M | 9.61M | 0.00 | 19.07M | 0.00 | |||
| Deferred Taxes/Income | 7.00K | 7.00K | 580.00K | N/A | N/A | |||
| Other Non-Current Liabilities | 3.57M | 4.42M | 3.06M | 3.20M | 8.70M | |||
| Total Non-Current Liabilities | 12.10M | 14.03M | 3.64M | 22.26M | 8.70M | |||
| TOTAL LIABILITIES | 26.78M | 26.16M | 20.62M | 27.67M | 12.95M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -127.94M | -78.45M | -47.17M | -126.17M | -102.07M | |||
| Additional Paid In Capital | 183.31M | 176.81M | 91.24M | 161.92M | 157.93M | |||
| Common Shares | 2.00K | 2.00K | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 1.56M | -1.50M | N/A | N/A | N/A | |||
| Shares Outstanding | 21.98M | 20.87M | 9.10M | 4.13M | 4.11M | |||
| Tangible Book Value per Share | 1.21 | 3.03 | 1.00 | 8.60 | 13.59 | |||
| Total Shareholders' Equity | 56.94M | 96.86M | 42.99M | 35.53M | 55.86M | |||
| TOTAL LIABILITIES AND EQUITY | 83.72M | 123.02M | 63.61M | 63.20M | 68.81M | |||
| Statistics | ||||||||
| Debt/Equity | 0.15 | 0.10 | N/A | 0.54 | N/A | |||
| Current Ratio | 3.38 | 6.98 | 1.54 | 10.72 | 11.60 | |||
| Return On Assets (ROA) | -53.45% | -25.43% | -40.28% | -38.13% | -33.21% | |||
| Return On Equity (ROE) | -78.59% | -32.30% | -59.60% | -67.83% | -40.91% | |||
All data in USD